CSL Limited
CSL LTD SP/ADRwww.csl.com
410
MENTIONS
163
EPISODES
67
PODCASTS
Search complete. 410 mentions across 163 episodes found for "CSL Limited".
Sep 11, 2026
Housing recession’s long shadow, Apple iPhone flip out & Trump’s insane cash splash
A
28:00Anthony MacdonaldHOST
Like you said, the share price has really been hit hard.
A
28:03Anthony MacdonaldHOST
It's been hit, you know, as hard as a CSL or Cochlear sort of thing, except it hasn't had that big dramatic sell-off.
A
28:08Anthony MacdonaldHOST
It's just been this trickle-
J
28:09James ThomsonHOST
Yeah
Afternoon Report | ASX hits six-week low
M
1:04Michael ThompsonHOST
Cochlear, for instance, was off more than 3%.
M
1:07Michael ThompsonHOST
CSL was down 2%, although that was trading ex-dividend.
M
1:11Michael ThompsonHOST
Higher oil and copper prices did help offset some of the losses.
M
1:15Michael ThompsonHOST
Woodside and Santos both rose.
PM 09 Sep 26: ASX slides on rising tensions
L
5:55Laura BesaratiHOST
But plenty of other stocks trading ex-dividend as well today.
L
5:58Laura BesaratiHOST
Now, I mentioned healthcare was down 1.5% and that's largely due to the largest stock in the sector, CSL.
L
6:05Laura BesaratiHOST
trading ex-dividend today as well among plenty of other stocks.
S
6:10speaker_0NARRATOR
On the winner's list has been shipbuilder
the COB: Hauser's hawkish hint
J
2:44Juliet SalhiHOST
And let's have a look at healthcare because that, the so-called defensive sector, was sold off today.
J
2:48Juliet SalhiHOST
CSL down 1.5%.
J
2:50Juliet SalhiHOST
ResMed, Cochlear, Pro Medicus, Mesoblast under pressure as well.
J
2:54Juliet SalhiHOST
Not a lot of corporate news around, but we did hear from Westgold targeting almost 30% production growth.
K
6:58Kai ChenGUEST
Yeah, absolutely.
K
6:59Kai ChenGUEST
I think it's, um, it's worrisome, but um, I, I do think in certain segments of the market that's already corrected and, uh, represents value.
K
7:06Kai ChenGUEST
Like, you know, especially the healthcare sector, we saw CSL coming back.
K
7:10Kai ChenGUEST
Um, they've already been beaten down and, you know, o- obviously in the resource sector with, um, the, the large copper miners and other commodity-producing miners, we are seeing them actually perform fairly well.
the call: Wednesday 9 September
M
8:24Mark GardnerGUEST
And, you know, because you've just got to play the percentages and say, well, it's, you know, everyone, nearly everyone gets knocked back.
M
8:33Mark GardnerGUEST
CSL got knocked back.
M
8:34Mark GardnerGUEST
I mean, it's not exactly easy.
M
8:36Mark GardnerGUEST
So I think it's probably on a long-term basis is, you know, a speccy buy here.
14 MINS LATER
M
23:08Michael GableGUEST
But I brought along a longer term chart.
M
23:10Michael GableGUEST
We could see this goes back just over 10 years.
M
23:12Michael GableGUEST
So I think there's just a bit of a lesson, whether it's Cochlear, whether it's CSL.
M
23:21Michael GableGUEST
There's people out there that say, look, it's a great business and there's a lot of market noise and take advantage of it, blah, blah, blah.
We Called this ASX Bottom: The Next Move is Even Better
S
1:32speaker_3SOUNDBITE_SPEAKER
So this allows a long runway for the healthcare sector to really thrive for the next 10, 20 years.
J
1:40Janine CoxHOST
I mean just looking at what the potential upside could be if we can see up here around 180 I would say is a potential for CSL and I'm just going to grab my tool there so I can if it behaves itself and it's up around 50% is a potential from that point there.
J
1:58Janine CoxHOST
So a pullback down closer to $105 would be a really nice little move and a push up from that I'd like to see.
J
2:05Janine CoxHOST
Price, pattern and time, having all of those things lined up increases your probability of these major turns providing the best opportunities.
F
4:39Filip TortevskiHOST
All right, well, let's get into the fun stuff.
F
4:40Filip TortevskiHOST
Janine Stocks.
J
4:41Janine CoxHOST
All right, shall we? CSL's the first one.
J
4:44Janine CoxHOST
So a lot of people have been excited about what CSL's done recently.
Fear & Greed Afternoon Report | 9 Sep 2026
M
1:04Michael ThompsonHOST
Cochlear, for instance, was off more than 3%.
M
1:07Michael ThompsonHOST
CSL was down 2%, although that was trading ex-dividend.
M
1:11Michael ThompsonHOST
Higher oil and copper prices did help offset some of the losses.
M
1:16Michael ThompsonHOST
Woodside and Santos both rose.
End of Day Report – Wednesday 9 September: No Bounce from the ASX -
O
3:30Oliver MatthewHOST
REITs down 0.6, tech down 0.7, staples not acting very defensive down 0.9, banks down 1%, telecoms also down 1%, discretionary stocks keep on getting hit from this rate hike in negativity down 1.1 and the worst performer today following the US was healthcare.
O
3:48Oliver MatthewHOST
CSL losing out down around 2% today.
O
3:50Oliver MatthewHOST
ProMedicus suffering from healthcare down and also tech down.
O
3:54Oliver MatthewHOST
It finishing off 1.8%.
How Value Investors Really Think About Risk | Wealthy + Wise Ep32
H
28:25Howard ColemanGUEST
The answer really is the better you know the business, the more easily you'll be able to tell.
H
28:31Howard ColemanGUEST
So for example, if I could just give a personal example with me and many Team Invest members, when CSL's share price collapsed, it had been ridiculously high.
H
28:41Howard ColemanGUEST
It was on a ridiculously high P.
H
28:43Howard ColemanGUEST
But when it collapsed and it got all the way down to less than 100%, Pretty much everybody in Team Investor would say, thank you, Mr.
H
28:51Howard ColemanGUEST
Market, what a wonderful bargain, because we knew the company well enough to know that it couldn't possibly be that damaging if this was a short-term thing that they'd get over.
H
29:03Howard ColemanGUEST
Now, they wouldn't necessarily get back to $300 in a hurry, but $90 was crazy.
H
29:09Howard ColemanGUEST
Now, on the other hand, if it was a company I didn't know at all, let's take, I don't know, some other biotech seeing as CSL's in something similar to that.
H
29:20Howard ColemanGUEST
And this biotech had never made a profit and its share price plunged.
Episode 217 - Dezi - MFA - Bird Flu - TVL in Secret Harbour - SignalSandra - STAUNCH!
J
58:42Joel HillHOST
The idea of bird flu mutating into some sort of human-to-human virus is mostly found in your dopey circle-jerk comment sections because it hasn't happened yet and no one's talking about it.
J
58:52Joel HillHOST
And if it does happen... we have the vaccine capacity to make vaccines on massive scale thanks to CSL, a great Australian company.
J
59:00Joel HillHOST
Great Australian
P
59:00Peter HoysteadHOST
company.
153 more episodes mention CSL Limited.
Create an account to see the whole feed, search across every transcript, and follow the entities you care about.